vTv Therapeutics
VTVT
44 hedge funds and large institutions have $18M invested in vTv Therapeutics in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
22% more funds holding
Funds holding: 36 → 44 (+8)
0.96% more ownership
Funds ownership: 0% → 0.96% (+0.96%)
38% less capital invested
Capital invested by funds: $29.1M → $18M (-$11.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
+$1.15M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$295K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$188K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$183K |
| 5 |
Morgan Stanley
New York
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.52M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$559K |
| 3 |
WSA
Wall Street Associates
Lajolla,
California
|
-$454K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$96.8K |
| 5 |
TG
TLP Group
Evanston,
Illinois
|
-$84K |
VTVT Hedge Fund Activity: Q4 2016 in Review
44 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2016, worth a combined $18M — down 38% from $29.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VTVT positions and 3 closed out — a net gain of 9 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $1.15M. The largest seller was Fidelity Investments, exiting entirely with an estimated $2.52M sold.
- 44 institutional investors held vTv Therapeutics (VTVT) as of Q4 2016, up from 36 in Q3 2016.
- Funds reported $18M of vTv Therapeutics stock for Q4 2016, down 38% quarter-over-quarter.
- 12 funds opened new vTv Therapeutics positions in Q4 2016 and 3 closed out, a net change of +9 holders.
- The largest vTv Therapeutics buyer in Q4 2016 was Ghost Tree Capital, an estimated $1.15M added.
- The largest vTv Therapeutics seller in Q4 2016 was Fidelity Investments, an estimated $2.52M sold.
Based on aggregated 13F filings for Q4 2016.